About us | About Scoope | Contact us
Scopelogo
 
google

 
  
 Sponsor Links
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Service provider > Information and Publishing Services > Web-based Information services > Oncology>
NEWS ARCHIVES ACROSS CATEGORY
  News archives across months
  News archives across themes
    News archives across category
 
  News articles recently covered under
Oncology

   
 

Future Medicine's eight Oncology Management Series of journals to convert to full open access from 2018
- 29 Jan 2018

Future Medicine has announced that its Oncology Management Series will be following a fully open access model, from January 2018. The eight journals within the Oncology Management Series are Breast Cancer Management; CNS Oncology; Colorectal Cancer; Hepatic Oncology; International Journal of Endocrine Oncology; International Journal of Hematologic Oncology; Lung Cancer Management and Melanoma Management.

The transition means that all content published from January 2018 onwards will be open access on www.futuremedicine.com. Access to all archive material is free for members of Oncology Central, an online oncology knowledge hub.

The journals cover key areas of oncology, publishing the latest findings and opinions related to the overall management of the respective disease areas. They explore the best patient-centered clinical research and present this information both directly, as clinical findings, and in practice-oriented formats of direct relevance in the clinic. The journals also highlight significant advances in basic and translational research, placing them in context for future therapy.

The Oncology Management Series of journals considers original research articles that have been conducted with scientific rigour and research integrity. They also accept case report submissions. Other article types considered include reviews, perspectives, editorials and commentaries, providing oncologists and other health professionals with high-quality information and discussion on these widespread diseases in a clear, accessible format. In addition, they also consider article proposals from nurse practitioners, patient advocates and the wider professional oncology community.

The journals will follow a gold open access model, publishing all articles under the Creative Commons CC-BY license to allow maximum dissemination. Authors are required to comply fully with the journal's Disclosure & Conflict of Interest Policy as well as major publishing guidelines, including ICMJE and GPP3. All research and review-style articles submitted to the journals will undergo double-blind peer review by a minimum of three independent experts.

Brought to you by Scope e-Knowledge Center, a trusted global partner for digital content transformation solutions - Abstracting & Indexing (A&I), Knowledge Modeling (Taxonomies, Thesauri and Ontologies), and Metadata Enrichment & Entity Extraction.

Click here

Society for Integrative Oncology gains access to UBM Medica's oncology distribution channels
- 01 Aug 2017

UBM Medica, a provider of educational resources to healthcare professionals, has announced a partnership with the Society for Integrative Oncology (SIO).

Through this partnership, SIO will gain significant reach into the cancer-treating community through UBM Medica's oncology distribution channels – the ONCOLOGY journal and CancerNetwork.com – allowing members of SIO greater access to information impacting the field of oncology as well as their day-to-day practice.

In turn, with the addition of one of SIO's key thought leaders to its respected editorial advisory board, the ONCOLOGY journal will be able to provide more relevant integrative oncology information to its readership, furthering SIO's mission to advance evidence-based, comprehensive, integrative healthcare to improve the lives of people affected by cancer.

Brought to you by Scope e-Knowledge Center, a world-leading provider of Abstracting & Indexing (A&I) Services, Knowledge Modeling Services (Taxonomies, Thesauri and Ontologies), Metadata Enrichment & Entity Extraction Services.

Click here

Elsevier publishes Practical Handbook to support Palliative Radiation Oncology
- 03 Mar 2017

STM publisher Elsevier has announced the publication of Handbook of Supportive and Palliative Radiation Oncology by Monica Krishnan, Margarita Racsa and Hsiang-Hsuan Michael Yu. A practical tool and rapid reference for radiation oncology practitioners in direct patient care, the book covers the most recent advances in translational palliative care research. It is organised in a succinct fashion to discuss major symptom burdens, suggested assessment and various management options. Elsevier also announced publication of two additional oncology and cancer research books.

Handbook of Supportive and Palliative Radiation Oncology begins by describing general approaches in palliative radiation oncology, followed by a section focused on common symptoms in palliative care and their management. The next section of the book is devoted to site and disease-specific evaluation, intervention and management. This handbook offers general guidelines and management recommendations for common clinical vignettes encountered by palliative radiation oncology practitioners and supported by palliative radiation oncology research, citing concise references to support treatment recommendations.

The three new oncology and cancer research titles are: Handbook of Supportive and Palliative Radiation Oncology by Monica Krishnan, Margarita Racsa and Hsiang-Hsuan Michael Yu; Translational Advances in Gynecologic Cancers by Michael Birrer and Lorenzo Ceppi; and Ecology and Evolution of Cancer by Beata Ujvari, Benjamin Roche and Frederic Thomas.

In order to meet content needs in oncology and cancer research, Elsevier uses proprietary tools to identify the gaps in coverage of the topics. Editorial teams strategically fill those gaps with content written by key influencers in the field, giving students, faculty and researchers the content they need to answer challenging questions and improve outcomes. These new books, which will educate the next generation of oncologists and cancer researchers, and provide critical foundational content for information professionals, are key examples of how Elsevier is enabling science to drive innovation.

Brought to you by Scope e-Knowledge Center, a world-leading provider of metadata services, abstraction, indexing, entity extraction and knowledge organisation models (Taxonomies, Thesauri and Ontologies).

Click here

Wiley to publish Molecular Oncology journal from January 2017
- 10 Aug 2016

Publisher John Wiley & Sons, Inc. has announced an extended publishing partnership with the Federation of European Biochemical Societies (FEBS) with the move of Molecular Oncology from January 2017 to join the other three FEBS publications published by Wiley - The FEBS Journal, FEBS Letters, and FEBS Open Bio at FEBS Press. FEBS has become one of Europe's largest organisations in the molecular life sciences, providing a voice to a large part of the academic research and teaching community in Europe.

With Molecular Oncology’s transition to Wiley, all four journals will be discoverable on the new FEBS Press platform on Wiley Online Library. FEBS Press will ensure the journals continue to serve and support the research community and remain the journals of choice for authors and readers.

Molecular Oncology publishes high-impact discoveries and technical advances in basic, clinical and discovery-driven translational cancer research, and has an Impact Factor of 5.367. When Molecular Oncology joins Wiley in January 2017 it will also make the change to become a fully Open Access journal.

Brought to you by Scope e-Knowledge Center, a world-leading provider of metadata services, abstraction, indexing, entity extraction and knowledge organisation models (Taxonomies, Thesauri and Ontologies).

Click here

Special issue of FSG published journal Future Oncology explores the field of Oncofertility
- 06 Jul 2016

Future Science Group (FSG) published journal, Future Oncology, has released a special issue that examines the field of oncofertility, which aims to preserve fertility in cancer patients.

As the field of cancer research has developed and improved, the numbers of patients surviving many years post-diagnosis is growing. This has led to prioritising cancer management and improving the quality of life in survivors.

In cases where the disease presents in children and young adults, their future fertility becomes an immediate concern, due to well-recognized effects of cancer treatments on reproductive function.

This special focus brings together a range of articles detailing the latest information across various facets of fertility management in cancer patients. Content includes original research into the specific effects of cancer treatment on tissues required for fertility preservation; expert commentaries on current, and in some cases controversial, techniques; and reviews' detailing what is known thus far and where we should be focusing our efforts in future.

A follow-up themed issue with further thought-provoking and informative content from the oncofertility field will be scheduled for release in October of 2016.

Brought to you by Scope e-Knowledge Center, a world-leading provider of metadata services, abstraction, indexing, entity extraction and knowledge organisation models (Taxonomies, Thesauri and Ontologies).

Click here

Journal of Oncology Practice goes to monthly distribution with new, enhanced resources
- 19 Jan 2016

The American Society of Clinical Oncology (ASCO) has announced that the Journal of Oncology Practice (JOP) will be printed on a monthly basis and offer new resources to supply oncology professionals with cutting-edge information on cancer care delivery. Doubling its content, the expanded journal also features clinical information from a multidisciplinary care team perspective led by new Deputy Editor, James O. Armitage, MD.

The print version of JOP will now be delivered on a monthly basis in its own solo mailing, doubling its frequency from six to twelve issues a year. All original reports will be presented in a novel, standardized format called ReCAP (Research Contributions Abbreviated for Print) - a short structured, summary of the study which highlights the central question being asked by the work, and outlines the main findings of the authors. ReCAP will provide more information than a classic abstract. The relevance of the work for practicing oncologists will be emphasized, as well as any factors that might affect interpretation of the study results. The full manuscript will be available online and is the official version of record. ReCAPs are intended to meet the needs of busy clinicians who need a concise overview and to increase the audience for this content.

In addition, each issue of JOP will now expand to include three clinical reviews that will focus on pertinent problems in delivering care. Dr. Armitage has been selected as the Deputy Editor of the new Clinical Review section, which provides highly practical, clinical reviews authored by thought leaders in oncology and relevant subspecialties. Additional experts will provide commentaries to accompany each review.

Currently, Dr. Armitage is the Joe Shapiro Professor of Medicine at the University of Nebraska Medical Center and past president of both ASCO and the American Society of Blood and Marrow Transplantation in addition to serving on numerous boards around the world. In his four decades of practice, Dr. Armitage has become globally recognised as a leading expert on non-Hodgkin lymphoma, and has played a critical role in advancing bone marrow transplantation. He begins his tenure as Deputy Editor of JOP having served on the Journal of Clinical Oncology Editorial Board and as Editor-in-Chief of The ASCO Post.

The expanded content and frequency will be delivered by a new publishing partner, Harborside Press. Harborside currently publishes The ASCO Post and is recognised in the industry as a provider of high-quality cancer information across a wide variety of media.

Brought to you by Scope e-Knowledge Center, a world-leading provider of abstraction, indexing, entity extraction and knowledge organisation models (Taxonomies, Thesauri and Ontologies).

Click here

American Society of Clinical Oncology launches new Journal of Global Oncology Editorial Fellowship
- 13 Nov 2015

The American Society of Clinical Oncology (ASCO) has announced the launch of its new Journal of Global Oncology Editorial Fellowship. The program will provide participants from low- and middle-income countries with an interactive introduction to scientific publishing.

The JGO Editorial Fellowship is currently accepting applications for the program's inaugural 2016 year. Applications are due December 15, 2015, and two fellows will be selected to participate.

Participants of the program will walk through the journal's peer review, editing, and publishing processes alongside current JGO editors and editorial board members. Program activities include the review of select manuscripts, decision-making in cooperation with associate editors, and attendance at JGO editorial meetings, which take place at the ASCO Annual Meeting in Chicago.

Participants who complete the program successfully will be expected to impart their acquired knowledge and skills to colleagues, thereby improving the quality of emerging research and scientific manuscripts produced from various regions of the world. Fellows will also be better equipped to serve as reviewers for the journal and be able to provide a valuable local perspective on submitted manuscripts.

Brought to you by Scope e-Knowledge Center, a world-leading provider of abstraction, indexing, entity extraction and knowledge organisation models (Taxonomies, Thesauri and Ontologies).

Click here

Elsevier to publish the Journal of Thoracic Oncology from January 2016
- 15 Oct 2015

STM publisher Elsevier and the International Association for the Study of Lung Cancer (IASLC) have jointly announced Elsevier's appointment as publisher of the IASLC's official journal, Journal of Thoracic Oncology (JTO), beginning January 2016.

Published since 2006, the Journal of Thoracic Oncology emphasizes a multidisciplinary approach including original research (clinical trials and translational or basic research), reviews, and opinion pieces. This peer-reviewed journal is the primary educational and informational publication for topics relevant to detection, prevention, diagnosis, and treatment of thoracic malignancies. It has a global author base and readership comprising epidemiologists, medical oncologists, radiation oncologists, thoracic surgeons, pulmonary specialists, radiologists, pathologists, and research scientists with a special interest in thoracic oncology.

Researchers, academic physicians, clinicians, and the libraries that serve them will have increased access to cutting-edge research through Elsevier's sophisticated online channels, which offer readers enhanced features and expanded discoverability, while authors benefit from seamless and easy dissemination of their important work.

With a significant Impact Factor of 5.282, JTO is ranked 30th out of 211 journals in Oncology and 7th out of 57 journals in Respiratory Medicine. Managing Editor Mary Sharkey Todd will continue to provide support and guidance to the JTO and IASLC community.

Brought to you by Scope e-Knowledge Center, a world-leading provider of abstraction, indexing, entity extraction and knowledge organisation models (Taxonomies, Thesauri and Ontologies).

Click here

ASCO publishes first articles in new Journal of Global Oncology
- 24 Sep 2015

The American Society of Clinical Oncology (ASCO) has announced the publication of seven articles in its new Journal of Global Oncology (JGO). The first articles for this online-only, open-access journal are now available at www.jgo.org.

The Journal of Global Oncology was founded to address cancer care, research, and care delivery issues unique to countries and settings with limited healthcare resources. It is estimated that nearly two-thirds of all cancer deaths today occur in low- and middle-income countries, and this is forecast to increase to 70 percent by 2030. While some journals publish special issues and sections focused on global oncology, JGO is the first peer-reviewed journal dedicated solely to this area of research.

The Journal of Global Oncology is funded through the Conquer Cancer Foundation of the American Society of Clinical Oncology with the support of the Doris Duke Charitable Foundation and Novartis Oncology. Expanded reach of the journal is made possible through collaboration between ASCO and the Union for International Cancer Control.

Brought to you by Scope e-Knowledge Center, a world-leading provider of abstraction, indexing, entity extraction and knowledge organisation models (Taxonomies, Thesauri and Ontologies).

Click here

ASCO and UICC partner to extend reach of Journal of Global Oncology
- 27 Aug 2015

The American Society of Clinical Oncology (ASCO) and the Union for International Cancer Control (UICC) have announced their partnership to expand the reach of the Journal of Global Oncology (JGO), a new open-access journal that will focus on cancer care, research, and care delivery issues unique to countries and settings with limited healthcare resources.

It is estimated that today nearly two-thirds of all cancer deaths occur in low- and middle-income countries (LMICs), and this is forecast to increase to 70 percent by 2030. While some journals publish special issues and sections focused on global oncology, JGO will be the first peer-reviewed journal dedicated solely to this area of research.

The partnership between ASCO, which boasts more than 35,000 members around the world, and UICC, whose membership represents more than 800 organisations in 155 countries, will extend the reach of the Journal to a broad international audience. ASCO and UICC will work together to solicit high-quality original research, secure funding, and promote the Journal to their respective networks.

Through this collaboration, ASCO and UICC will meet a growing need for high-quality clinical cancer research in LMICs by providing a peer-review platform focused on the challenges faced by researchers and care providers in these countries.

The Journal of Global Oncology is funded through the Conquer Cancer Foundation of the American Society of Clinical Oncology with the support of the Doris Duke Charitable Foundation and Novartis Oncology.

Brought to you by Scope e-Knowledge Center, a world-leading provider of abstraction, indexing, entity extraction and knowledge organisation models (Taxonomies, Thesauri and Ontologies).

Click here

American Society of Clinical Oncology invites authors to submit papers to new OA journal, Journal of Global Oncology
- 05 Jun 2015

The American Society of Clinical Oncology (ASCO) and Dr. David Kerr, founding Editor-in-Chief of the Society's new Journal of Global Oncology, are inviting authors to submit their next article to this new online-only, open access journal.

Journal of Global Oncology fulfills a growing need for high-quality literature on the array of challenges that healthcare professionals in resource-constrained settings face in caring for patients with cancer and in conducting research. Articles will cover cancer treatment and diagnosis, palliative and supportive care, prevention, barriers to care, epidemiology, and health policy. Article types that will be considered include original reports, reviews, commentaries, correspondence, special articles, case reports, and editorials.

First articles are scheduled to be published in the third quarter of 2015. Details about Journal of Global Oncology and article submissions are online at http://www.GlobalOncologyJournal.org

ASCO also publishes Journal of Clinical Oncology and Journal of Oncology Practice.

IOP Publishing’ new Convergent Science Physical Oncology journal to bring together all researchers in the field of the physics of cancer
- 04 Dec 2014

Non-profit scientific publisher IOP Publishing has announced the launch of Convergent Science Physical Oncology journal. The journal claims to be the first and only interdisciplinary title dedicated to bringing together all researchers in the field of the physics of cancer.

From oncologists, cancer biologists, patient advocates, pharmacologists and physicists, to scientists working in biophysics, mathematics, chemistry and bioengineering, the journal will help researchers address the major questions and barriers in cancer research.

Currently, interdisciplinary papers arising from this research are published in a diverse range of subject specific journals, but authors face multiple challenges during the peer-review process because of a lack of common language between the disciplines. Once papers are eventually published they often do not reach their full audience.

To help address this problem, IOP has recruited four equal Founding Editors: an oncologist, a physicist, a pathologist and a patient advocate – to provide appropriate editorial coverage and ensure that the journal fulfils its goal of reducing the barriers between the researchers in different disciplines working on the same questions from different angles.

The Founding Editors are Professor Peter Kuhn, PhD (University of Southern California, USA), Dr Kelly Bethel, MD (Scripps Clinic, USA), Dr Jorge Nieva, MD (University of Southern California, USA) and Dr Carole Baas, PhD (National Cancer Institute, USA). The team of Founding Editors will be supported by a group of section editors, and an international editorial board.

To accelerate high-quality review for the authors, the board will also facilitate an informal open discussion between reviewers to address the challenge of translating research between the disciplines and enabling constructive peer review. This break from traditional peer review is expected to become a new standard for the journal.

The editorial board is inviting submissions from across the physical oncology community.

As part of the journal's launch phase, all content in the journal will be free to read for individual users, universities and academic research institutes throughout 2015. The journal will also offer open-access publishing options.

Click here

SAGE set to publish Technology in Cancer Research & Treatment journal
- 25 Jul 2014

Academic publisher SAGE has announced that it will begin publication of the bi-monthly journal, Technology in Cancer Research & Treatment (TCRT), currently published by Adenine Press of Schenectady, New York. The first issue of TCRT to publish with SAGE will be Volume 14, Issue 1 in February 2015.

Established more than a decade ago, TCRT publishes original research and review articles on technologies that facilitate early diagnosis, treatment, and palliation of cancer, with special emphasis on non-invasive procedures. TCRT’s 2012 Impact Factor of 1.943 reflects its success and influence in the field of oncology research.

Among the topics covered in TCRT are MRI including functional MRI, spiral CT, PET, optical spectroscopy, computer-aided reconstruction of tumors, computer-aided drug design, stereotactic radiosurgery, gene therapy, cancer vaccine and many more issues that directly impact cancer research and treatment.

UBM Medica US launches new resource for oncologists, OncoTherapyNetwork.com
- 13 May 2014

UBM Medica US has announced the launch of OncoTherapyNetwork.com – a new online community and information resource for oncologists and cancer care professionals about the use of targeted therapy and immunotherapy.

With the number of newly approved and pipeline drugs rapidly growing, targeted therapies and immunotherapies are becoming the treatments of choice for more and more clinicians. Visitors to the site can keep up with new and emerging information focused specifically on advances in this treatment area.

The new OncoTherapyNetwork.com will feature blogs written by MDs for MDs about the unique challenges of employing these agents; podcasts, videos, and webinars featuring key opinion leaders best practices in these emerging therapeutic areas; highlights from key conferences; and short quizzes specific to these new agents.

Addressing today's healthcare information needs, UBM Medica US, delivers strategic, integrated communications solutions and comprehensive reach - online, in print, via custom programs and live events. Improving the effectiveness of healthcare through information and education, UBM Medica US provides unbiased clinical, practical, and business information for physicians, providers and payers resulting in improved quality of care for patients around the world. Through journals, magazines, online communities, live and digital events, and other valuable resources, UBM Medica US also delivers comprehensive communication solutions for the pharmaceutical and related industries.

Click here

De Gruyter Open and Hellenic Society of Medical Oncology announce publishing agreement
- 06 May 2014

Open access publisher De Gruyter Open has become the publisher of the Forum of Clinical Oncology journal. The journal is the quarterly chief publication of the Hellenic Society of Medical Oncology (HeSMO).

The Forum of Clinical Oncology aims to provide an enhanced educational opportunity to physicians treating patients with neoplastic diseases and to serve researchers as an essential communication tool and valuable knowledge resource for the community. The journal is dedicated to the ever-expanding spectrum of cancer research. It publishes original and translational research articles relevant to diagnosis and treatment, state-of-the-art reviews, case reports, research articles, statements of opinion and comments – all related to clinical practice and basic research.

As an international journal, FCO places special focus on the Balkans and the Mediterranean area, to foster the communication and exchange of information and to promote collaboration between practicing clinicians and basic research scientists. The journal reflects the Society's aim to advance clinically-relevant knowledge of cancer.

Prospective readers and contributors are encouraged to visit the journal's homepage: www.degruyter.com/view/j/fco where articles will be available immediately as open access upon publication.

Click here

Elsevier publishes five new cancer therapy books
- 08 Apr 2014

STM publisher Elsevier has announced the publication of five new cancer therapy books, including Cancer Theranostics, edited by Xiaoyuan Chen and Stephen Wong. All of the new books will be featured at this week’s American Association for Cancer Research (AACR) Annual Meeting April 5-9 in San Diego at Elsevier’s booth #635.

As part of the trend toward personalised treatment of cancer, cancer theranostics is an approach for diagnosing and treating cancer that aims to eliminate multi-step procedures, reduce delay in treatment and ease patient care, all of which are important factors for personalized cancer treatment. The new book, Cancer Theranostics, reviews, assesses and makes pertinent clinical recommendations on the integration of comprehensive in vitro diagnostics, in vivo molecular imaging and individualized treatments towards the personalization of cancer treatment. It also describes the identification of novel biomarkers to advance molecular diagnostics of cancer and discusses nanotechnology platforms incorporating cancer imaging, therapeutic components, clinical translation and future perspectives.

Dr. Chen, the principal editor of Cancer Theranostics, is an expert in the fast-developing field of theranostics and cancer prognosis. He is Senior Investigator and Lab Chief at the National Institute of Biomedical Imaging and Bioengineering, part of the National Institutes of Health.

The five new cancer therapy books published are: Cancer Theranostics by Xiaoyuan (Shawn) Chen and Stephen Wong; Cancer: Oxidative Stress and Dietary Antioxidants by Victor Preedy; Mesenchymal Stem Cells in Cancer Therapy by Khalid Shah; Biomaterials for Cancer Therapeutics: Diagnosis, Prevention and Therapy by Kinam Park; and Cancer Genomics: From Bench to Personalized Medicine by Graham Dellaire, Jason Berman and Robert Arceci.

The books are available on the Elsevier Store and on ScienceDirect, Elsevier’s full-text scientific database offering journal articles and book chapters from more than nearly 2,200 peer-reviewed journals, almost 900 serials and 25,000 book titles.

Click here

PMPH-USA announces publication of Hepatobiliary Cancer
- 24 Jan 2014

Medical publishing house PMPH-USA has announced the publication of Hepatobiliary Cancer edited by Yuman Fong of Sloan Kettering Cancer Center and Jia-hong Dong of the Chinese PLA General Hospital in Beijing, China, both internationally recognized for their research and expertise in liver and biliary surgery. Section editors are Ghassan Abou-Alfa and Gary E. Deng of Memorial Sloan Kettering Cancer Center and Dr. Damian Dupuy of the Warren Alpert Medical School at Brown University.

With the technological advances in imaging and therapy over the past two decades, hepatobiliary cancer no longer carries a prognosis of certain death. This concise yet comprehensive text reflects the most current approaches and technology used at major cancer treatment facilities around the world in the management of liver and biliary cancers. It is an international collaboration of world authorities in the areas of surgery, chemotherapy, radiation therapy, medical oncology, and integrative medicine. Chapters summarise the state-of-the-art therapies with algorithms of care and potential directions for future evolution. It is beautifully illustrated with numerous tables and colour surgical and radiographic images.

Authors of the 24 chapters are affiliated with major cancer centers around the globe including Memorial Sloan Kettering Cancer Center in New York, PLA Hospital in Beijing, Fudan University Shanghai Cancer Center and The University of Hong Kong (China), University of Heidelberg (Germany), University of Liverpool and University of Birmingham (UK), University of Tokyo and Research Center for Innovative Oncology (Japan), and Sanjay Gandhi Institute (India). Other US affiliations include Columbia University, Fineberg School of Medicine at Northwestern University,Warren Alpert Medical School of Brown University, Johns Hopkins Hospital, the Mayo Clinic, David Geffen School of Medicine at UCLA, University of Medicine and Dentistry of New Jersey, and Florida International University College of Medicine.

Dr. Yuman Fong is Murray F. Brennan Chair in Surgery and Co-Director of Center for Image-guided Interventions at Memorial Sloan-Kettering Cancer Center and Professor of Surgery at Weill Cornell Medical College. He is well-known internationally for his research and pioneering work in developing minimally invasive surgery and ablative therapies for hepatobiliary cancer. He has co-authored over 500 peer-reviewed articles and served on editorial boards of 14 journals. He currently serves as Chair of the recombinant DNA advisory committee of the National Institutes of Health.

Dr. Jia-Hong Dong is Professor and Chairman, Hospital & Institute of Hepatobiliary Surgery, Chinese PLA General Hospital, Chinese PLA Medical Postgraduate School, Beijing, China.

Future Medicine Ltd. expands portfolio of oncology journals with the launch of Hepatic Oncology
- 10 Jan 2014

Future Medicine Ltd., part of Future Science Group, UK, has announced the launch of the new journal - Hepatic Oncology. This new title focuses specifically on the specialism of hepatic cancer, including both primary and secondary malignancies.

Hepatic Oncology is published by Future Medicine Ltd, and joins its portfolio of oncology journals providing healthcare practitioners and research professionals with a unique source of objective, cutting-edge information on exciting trends emerging in light of advances in medicine, healthcare and clinical practice.

Hepatic Oncology provides a forum to report and debate all aspects of cancer of the liver and bile ducts. The journal publishes original research studies, full reviews and commentaries, with all articles subject to independent review by a minimum of three independent experts. Unsolicited article proposals are welcomed and authors are required to comply fully with the journal's Disclosure & Conflict of Interest Policy as well as major publishing guidelines, including ICMJE and GPP2.

The direction of the journal is led by a team of three Senior Editors, Dr Jordi Bruix (University of Barcelona), Professor Richard Finn (UCLA) and Professor Ronnie TP Poon (The University of Hong Kong), along with an international Editorial Board of experts in the field.

Click here

Oncology journal Cancer Science adopts Open Access
- 10 Sep 2013

Publisher John Wiley and Sons, Inc., US, has announced that Cancer Science has become the first Japanese journal of its size to transition to open access, by joining the Wiley Open Access publishing program. From January 1, 2014, all newly published articles will be open access and free to view, download and share.

As the journal of the Japanese Cancer Association, Cancer Science has been publishing high quality oncology research since its launch in 1907 as Gann, before being retitled as the Japanese Journal of Cancer Research. The journal now attracts over 1,300 submissions annually worldwide and has attained an Impact Factor of 3.479, establishing its role as the leading oncology journal in Asia.

As part of the Wiley Open Access program authors, their funding agencies, or their institutions can pay an Article Publication Charge (APC), to ensure that the article is made available to non-subscribers upon publication via Wiley Online Library, as well as deposited in PubMed Central (PMC) and PMC mirror sites.

Click here

BioMed Central launches Journal for ImmunoTherapy of Cancer
- 31 May 2013

Open access publisher BioMed Central, UK, and the Society for Immunotherapy of Cancer (SITC) have announced the launch of the Journal for ImmunoTherapy of Cancer (JITC). JITC is an open access, peer reviewed journal that encompasses all aspects of tumor immunology and cancer immunotherapy, from basic research through to clinical applications.

As the official journal of SITC, JITC will be the cancer immunotherapy community's prime forum to discuss the critical issues in tumor immunology and cancer immunotherapy research, with an audience of the most influential names in the field. The journal is overseen by Editor-in-Chief Pedro Romero, as well as an Editorial Board of outstanding leaders in both basic and clinical tumor immunology and cancer immunotherapy fields.

SITC members will also receive waived article processing charges for manuscripts published in the journal during 2013.

Click here

Thieme launches open access journal, ‘Metabolism and Nutrition in Oncology’
- 07 May 2013

STM publisher Thieme Publishing Group, Germany, has announced the launch of a new open access (OA) journal, Metabolism and Nutrition in Oncology (MNO). The online journal is dedicated to the interplay of dietary food habits, food, nutrients, metabolism and cancer. Its editorial board includes four experts in the field: Jann Arends, Hartmut Bertz, Paul Urbain (all Freiburg) and Hans Konrad Biesalski from Stuttgart.

Covering all aspects of metabolic pathways in cancer, MNO publishes content investigating the pathophysiology of metabolic maldevelopment, as well as the differentiation of metabolic pathways in healthy compared to cancerous tissues. Over the past decades, advances made in cancer research have shown the reaction of single nutrients, both in an isolated state and in association with other complexes. Research has further presented evidence for singular nutrients to display both positive and negative effects, on the development of neoplastic cells, as well as interacting cancer therapies. By focusing on metabolic processes in cancer, MNO aims to encourage researchers to study the relationship between tumour metabolism and food products and their characteristic nutritional components.

MNO seeks to publish original research, review articles and case reports. Rapid communications are also accepted with expedited processing times for the release of the very latest research results. All articles submitted to MNO undergo rigorous peer review. As an open access journal, all articles are made freely available for all to read and download from Thieme E-Journals. Additionally, print issues are available on demand.

To learn more about the journal of Thieme please visit http://www.thieme.com/mno.

BioMed Central launches a new journal Cancer & Metabolism
- 24 Jan 2013

Open access publisher BioMed Central has announced the launch of a new journal Cancer & Metabolism with a selection of articles that highlight the altered metabolic pathways that drive cancer.

The launch issue of the journal includes pioneering research that for the first time observes the Warburg effect during normal cerebellum development, as well as in medulloblastoma, a childhood cancer, which is accompanied by a Commentary in BMC Biology; a study on the crucial role of sterol regulatory element binding protein in lipid synthesis for cell survival and tumor growth; new imaging methods for measuring chemotherapy responses; as well as timely reviews on activated lymphocytes as a model for carcinogenesis and the discovery of the mitochondrial pyruvate carrier.

Cancer & Metabolism is edited by clinician scientists Chi Van Dang, Abramson Cancer Center, USA, and Michael Pollak, Segal Cancer Center and McGill University, Canada. The journal welcomes studies on molecular biology and genetics; whole-body metabolism, including diabetes and obesity, in relation to cancer; cancer metabolomics and metabolism-based imaging. The journal accepts basic research as well as preclinical and clinical studies of metabolism-related cancer therapies.

Click here

Elsevier to publish Cytotherapy: The Journal of Cell Therapy
- 09 Jan 2013

STM publisher Elsevier, Netherlands, has announced that the International Society for Cellular Therapy (ISCT) has selected Elsevier to publish Cytotherapy: The Journal of Cell Therapy, effective January 2013.

Cytotherapy claims to be a highly influential publication in the mainstream of the rapidly expanding field of cell-based treatments for cancer, degenerative disorders, immunotherapy and stem cell transplantation. The journal publishes cutting edge findings, clinical trials of cell-based therapies, and news and opinion on all aspects of these disciplines. It focuses especially on the practical translation of scientific developments in the laboratory into clinical practice.

Cytotherapy is an essential global resource for clinical researchers, oncologists, hematologists, doctors, and regulatory experts involved in cell processing and therapy.

Click here

Future Science Group launches CNS Oncology journal
- 13 Sep 2012

Publisher Future Science Group has announced the launch of the first issue of its new bimonthly title, CNS Oncology.

CNS Oncology will provide oncologists with updates on key issues in screening, diagnosis, imaging, surgery, radiation, chemotherapy, targeted therapeutics and palliative care by exploring the best patient-centered clinical research and presenting this information both directly, as clinical findings, and in practice-oriented formats of direct relevance in the clinic. The journal will take the lead in generating discourse and debate with the aim of improving outcome for brain tumor patients.

CNS Oncology is latest of Future Science Group's recent launches to focus on clinical cancer management and follows new titles for 2012, Breast Cancer Management and Lung Cancer Management. Another edition to this exciting portfolio, International Journal of Hematologic Oncology, will be launched in October.

Senior Editors, Henry S Friedman (Duke University Medical Center, USA) and Alba A Brandes (Azienda USL of Bologna, Italy), envisage the new addition to Future Science Group's portfolio will play a major role in disseminating current opinion on the treatment of patients with brain tumors to a broad constellation of physicians and scientists involved in the neuro-oncology field. The Senior Editors are supported by a team of six Associate Editors, together with an Advisory Panel of 32 international experts.

The Editorial Office is now actively soliciting contributions of original research, reviews and commentary articles for the journal. Clinical studies in any aspect of CNS oncology are encouraged.

Click here

Springer and Breast Cancer Research Foundation announce publishing partnership
- 14 Aug 2012

STM publisher Springer has announced that it will publish a series of books in cooperation with The Breast Cancer Research Foundation (BCRF), starting 2013. Four books will be published annually, and will be included in the Springer series Advances in Experimental Medicine and Biology. The scope and focus of the volumes will encompass important cohesive themes in the area of breast cancer research, with the aim to conceptually advance the field.

BCRF was founded in 1993 by the late Evelyn Lauder and has funded several major breakthroughs in breast cancer. BCRF will hold editorial responsibility for the books and Springer will handle production, marketing, sales and distribution. The books will be available as eBooks on Springer's online platform www.springerlink.com and in print-to-order (PTO) format.

Spearheading the editorial development of these books are Dr. Larry Norton, BCRF Scientific Director, and Deputy Physician-in-Chief for Breast Cancer Programs and Medical Director of the Evelyn H. Lauder Breast Center at Memorial Sloan-Kettering Cancer Center, and Dr. Clifford Hudis, Chairman of the BCRF Scientific Advisory Committee and Chief of Breast Cancer Medicine Service at Memorial Sloan-Kettering.

Click here

National Comprehensive Cancer Network launches new online resource for the Chinese oncology community
- 25 May 2012

The National Comprehensive Cancer Network (NCCN) has launched NCCNChina.org.cn, an online resource for the Chinese oncology community.

Designed by the Charlesworth Group, NCCNChina.org.cn currently features the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) - China Editions. Based on the NCCN Guidelines, the China Editions comprise the extensive expertise of more than 100 Chinese cancer specialists in collaboration with NCCN panel experts.

The China Editions contain recommendations revised specifically to account for genetic, pharamacological, and regulatory considerations of the Chinese population.

The NCCN, a not-for-profit alliance of 21 of the world's leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.

Future Medicine launches new journal - Breast Cancer Management
- 25 May 2012

Future Medicine Ltd., part of Future Science Group, UK, has announced a further addition to its journal portfolio with the launch of a new bimonthly title, Breast Cancer Management. The journal seeks to provide a rapid-publication platform for debate and the presentation of new findings in the field of breast cancer treatment.

Breast Cancer Management addresses key issues in disease management by exploring the best patient-centered clinical research and presenting this information both directly, as clinical findings, and in practice-oriented formats of direct relevance in the clinic. The journal also highlights significant advances in basic and translational research, and places them in context for future therapy.

The Editorial Board comprises global opinion leaders in breast cancer research and clinical practice, selected specifically to ensure a balanced range of expertise that covers all clinical disciplines, as well as translational researchers involved in breast cancer management. Senior Editors V. Craig Jordan from Georgetown University Medical Center, US, and Mike Dixon from University of Edinburgh, UK, are supported by two Associate Editors, together with an Advisory Panel of 26 international experts.

The editorial office is now actively soliciting contributions of reviews, perspectives and editorial articles for the journal.

Click here

BioMed Central journal Experimental Hematology & Oncology now accepting submissions
- 01 Mar 2012

Open access publisher BioMed Central, UK, has announced that its journal Experimental Hematology & Oncology is now accepting submissions. The journal will make a deliberate effort in publishing clinical trials with ‘negative’ results and basic science studies with provocative findings.

The journal aims to publish original work, hypothesis, commentaries and timely reviews in the field of hematology and oncology. With open access, rapid turnaround time from submission to publication and online live comments from readers, Experimental Hematology & Oncology strives to be the hub for disseminating new knowledge and discussing controversial topics for both basic scientists and busy clinicians in the field of hematology and oncology.

Hematology and oncology are closely related and rapidly changing fields. The journal acts as an international platform for sharing laboratory findings in these areas.

Search for more Oncology related STM journals



Click here

Cancer & Metabolism journal now accepting submissions
- 13 Feb 2012

Open access publisher BioMed Central, UK, has announced the launch of a new interdisciplinary journal - Cancer & Metabolism. The journal is edited by pioneering clinician scientists Chi Van Dang, University of Pennsylvania, USA, and Michael Pollak, McGill University, Canada.

Chi Van Dang is director of the Abramson Cancer Centre and established the first mechanistic link between the Myc oncogene and cellular energy metabolism. Michael Pollak leads a research group at the Lady Davis Institute, which demonstrated a role for insulin and insulin-like growth factors in cancer biology, research that led to the development of new drugs.

Cancer & Metabolism welcomes studies on molecular biology and genetics; whole-body metabolism, including diabetes and obesity, in relation to cancer; cancer metabolomics and metabolism-based imaging. The journal accepts basic research as well as preclinical and clinical studies of metabolism-related cancer therapies.

To access our daily STM news feed through your iPhone, iPad, or other smartphones, please visit www.myscoope.com for a mobile friendly reading experience.


Click here

Maney Publishing in deal to publish Journal of Chemotherapy
- 10 Feb 2012

Academic publisher Maney Publishing, UK, has entered into an agreement to become the publisher of the Journal of Chemotherapy, starting immediately, with the first issue of the 2012, Volume 24, publishing in March. The journal is published under the auspices of La Società Italiana di Chemioterapia (the Italian Society of Chemotherapy).

The Journal of Chemotherapy is well known to researchers and clinical pharmacologists internationally; and will continue to publish on new cancer therapies and antibiotics as it has done over the last two decades.

The journal publishes experimental and clinical research articles, reviews, brief communications and letters in English on all aspects of antimicrobial, anticancer and immunomodulating chemotherapy, including: antibiotics, antifungals, antivirals, and anticancer drugs. Authors will be able to submit their articles online via a new Online Submission and Refereeing System.

Authors may opt for an open access route for publication, but otherwise will no longer be charged a fee to publish. Maney will publish articles online ahead of print via its host platform ingentaconnect which will also include Journal of Chemotherapy issues dating back to 1999.

The journal is included in Medline, Scopus, and Thomson Reuters Web of Science. The Journal of Chemotherapy has a 2010 impact factor of 1.145.

Search for more Oncology related academic journals

To access our daily STM news feed through your iPhone, iPad, or other smartphones, please visit www.myscoope.com for a mobile friendly reading experience.


Click here

Wiley-Blackwell announces new Wiley Open Access journal, Cancer Medicine
- 17 Jan 2012

Wiley-Blackwell, the STM and scholarly publishing business of John Wiley & Sons, Inc., US, has announced the launch of Cancer Medicine, a new Wiley Open Access journal.

Cancer Medicine is a peer reviewed, open access, interdisciplinary journal providing rapid publication of cutting edge research from global biomedical and clinical researchers across all the oncologic specialties in cancer biology, clinical cancer research and cancer prevention. The journal's promise of full global reach is reinforced by its editorial leadership and support from prestigious journals and societies. It is supported by three major cancer societies - American Cancer Society (ACS), Union for International Cancer Control (UICC) and Japanese Cancer Association (JCA).

Cancer Medicine is steered by Editor-in-Chief Dr. Qingyi Wei, a highly published and cited author based at the world's leading cancer research center in the US. Dr. Wei's previous editorial work includes a role as a Senior Editor on the American Association for Cancer Research's journal, Cancer Epidemiology, Biomarkers & Prevention. His research is aimed at identifying individuals at high risk of developing cancer.

The journal is currently open to submissions and aims to publish its first content online in Spring 2012.

Search for more Oncology related STM journals

To access our daily STM news feed through your iPhone, iPad, or other smartphones, please visit www.myscoope.com for a mobile friendly reading experience.


Click here

Thieme publishes fourth edition of 'Teaching Atlas of Mammography'
- 05 Dec 2011

STM publisher Thieme Publishing Group, Germany, recently published the new fourth edition of Teaching Atlas of Mammography. The publication is authored by Dr. Laszlo Tabar, Professor of Radiology, University of Uppsala School of Medicine, and Dr. Peter B. Dean, Professor, Department of Diagnostic Radiology, University of Turku, Finland.

In the latest edition, readers are again invited to share in the authors’ experience of analyzing and evaluating mammograms. According to the publisher, their systematic approach not only instils a full understanding of the principles of mammography but also provides the requisite knowledge and tools to arrive at a highly accurate differential diagnosis.

The purpose of this Atlas is to teach radiologists how to analyse mammograms and arrive at the correct diagnosis through proper evaluation of the findings. The illustrated cases are seen to cover practically the entire spectrum of breast abnormalities. They are based upon referred patient material as well as upon a large number of mammographic screening examinations. This edition includes the outcome of screen-detected cases followed for up to 25 years.

Teaching Atlas of Mammography and the Breast Cancer book series are projected to be essential for residents in radiology and practicing radiologists. Such professional are said to need the highest level of training in the radiologic anatomy of the normal breast and the changes associated with benign and malignant lesions. Thieme’s resources are stated to help ensure that all clinicians acquire the optimal technique and knowledge of pathologic processes necessary to reach a correct diagnosis and achieve the best long-term outcomes for their patients.

To access our daily STM news feed through your iPhone, iPad, or other smartphones, please visitwww.myscoope.com for a mobile friendly reading experience.

Elsevier launches iPad Edition of the European Journal of Cancer
- 27 Sep 2011

STM publisher Elsevier, Netherlands, has announced the launch of the iPad edition of the European Journal of Cancer (EJC). Starting with the September 2011 issue, all 18 annual issues of the EJC will be available through the EJC App on the App Store. iPad editions feature the same high quality articles that are published in the print as well as online editions.

The EJC is an international multidisciplinary oncology journal that publishes original research, editorial comments, review articles and news on basic and preclinical research, clinical oncology (medical, paediatric, radiation, surgical), translational oncology, and on cancer epidemiology and prevention. Led by Editor-in-Chief, Alexander Eggermont, the journal is the official journal of the EORTC (the European Organisation for Research and Treatment of Cancer, ECCO (the European CanCer Organisation), the EACR (European Association for Cancer Research), and EUSOMA (the European Society of Breast Cancer Specialists).

The EJC App includes published content from the EJC News and EJC News Focus, and offers readers the ability to customise the journal by selecting articles, tables, or figures to store and use later, as well as making notes on articles.

The EJC App offers unprecedented portability to its readers, who can download the edition wirelessly. It is then available for reading and browsing offline, at times and in places where web access is not available. Of perhaps most significance, the journal can be read the same way on iPad as in print. The reader can flip pages forward and backward in the horizontal plane and scroll down vertically to read an individual article.

The EJC App is available for free from the App Store.

Search for more Oncology related information

To access our daily STM news feed through your iPhone, iPad, or other smartphones, please visit www.myscoope.com for a mobile friendly reading experience.


Click here

European Society for Medical Oncology partners with Thomson Reuters to launch new portal for oncologists
- 10 Aug 2011

The European Society for Medical Oncology (ESMO) has announced a partnership with global information and news organisation Thomson Reuters to launch a scientific information and education portal - OncologyPRO. The new site is designed to help oncologists keep up to date with the latest research and clinical information in their field.

OncologyPRO - Oncology Professional Resources Online seeks to provide ESMO members an unparalleled resource. The site integrates regularly updated oncology news, clinical research, biomarker and drug databases, practice guidelines and tools, clinical trial information, abstracts from more than 110 oncology-relevant journals and more, in a simple, searchable platform.

OncologyPRO provides access to materials developed by ESMO such as congress webcasts and reports, clinical practice guidelines, CME publications and policy documents, in addition to a wider range of scientific information and news services offered by Thomson Reuters.

Search for more Oncology related portals

To access our daily STM news feed through your iPhone, iPad, or other smartphones, please visit www.myscoope.com for a mobile friendly reading experience.


Dr. Fadlo Khuri named Editor in Chief of American Cancer Society journal, Cancer
- 04 Aug 2011

Cancer, a peer-reviewed journal of the American Cancer Society, has announced the appointment of Dr. Fadlo Khuri as the new Editor-in-Chief of the journal. Dr. Khuri will begin his term on September 1, 2011. He succeeds Dr. Raphael E. Pollock, who leaves the position after 11 years of service. Dr. Khuri has accepted a 5-year term for the editorship.

Dr. Khuri is Professor and Chair of Hematology and Medical Oncology at Emory University, the Deputy Director for the Winship Cancer Institute of Emory University, and Roberto C. Goizueta Distinguished Chair in Cancer Research. He has served as editor for the journal's lung section since 2005. His clinical interests include thoracic and head and neck oncology. His research interests include development of molecular, prognostic, therapeutic, and chemopreventive approaches to improve the standard of care for patients with tobacco-related cancers.

Dr. Khuri also serves as a grant reviewer for the American Cancer Society, National Cancer Institute, the American Association for Cancer Research, and the American Society of Clinical Oncology. He has published more than 200 peer-reviewed articles and has received numerous awards, including the Nagi Sahyoun Award from the Middle East Medical Assembly and the Waun Ki Hong Award from MD Anderson Cancer Center for his work on targeting signaling pathways in lung and aerodigestive cancers.

Published by Wiley-Blackwell, Cancer is a peer-reviewed publication of the American Cancer Society integrating scientific information from worldwide sources for all oncologic specialties. The objective of the journal is to provide an interdisciplinary forum for the exchange of information among oncologic disciplines concerned with the etiology and course of human cancer.

To access our daily STM news feed through your iPhone, iPad, or other smartphones, please visit www.myscoope.com for a mobile friendly reading experience.


Click here

Mary Ann Liebert, Inc. launches new journal on adolescent and young adult oncology
- 05 May 2011

Publisher Mary Ann Liebert, Inc., US, has launched a new peer-reviewed journal - Journal of Adolescent and Young Adult Oncology (JAYAO) - as part of a movement to transform cancer care and survivorship for adolescent and young adult (AYA) patients. The inaugural issue is available free online.

The journal is projected as an essential resource for a multidisciplinary audience, including pediatric, adult, and surgical oncologists of all types and specialties; oncology nurses and advanced practice staff; psychosocial and supportive care providers including psychiatrists, psychologists, and social workers; translational cancer researchers; and academic and community-based pediatric and adult cancer institutions.

The journal is under the expert editorial leadership of Editor-in-Chief Leonard S. Sender, MD, of the University of California, Irvine and CHOC Children's Hospital. He will be supported by a multidisciplinary international Editorial Board including prominent associate editors and section editors representing the AYAO-relevant subspecialties of breast cancer, gastrointestinal oncology, gynecologic oncology, head and neck cancer, leukemia and lymphoma, melanoma, neuro-oncology, oncofertility, radiation oncology, testicular cancer, sarcoma, and psychosocial and survivorship issues.

Search for more Oncology related Medical Journals

To access our daily STM news feed through your iPhone, iPad, or other smartphones, please visit www.myscoope.com for a mobile friendly reading experience.


Click here

LWW launches 9th edition of DeVita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology
- 11 Apr 2011

Healthcare publisher Lippincott Williams & Wilkins (LWW), part of Wolters Kluwer Health, US, has announced the publication of the Ninth Edition of DeVita, Hellman and Rosenberg's Cancer: Principles & Practice of Oncology. The publication is recognised as one of the most comprehensive oncology references in the world.

This comprehensive and timely single-volume print and electronic oncology reference contains leading-edge information. It includes expanded coverage of molecular biology, personalised cancer medicine and the recent explosion of targeted therapies. The revamped art programme contains hundreds of brand-new full-colour illustrations.

This new edition, scheduled for publication in May 2011, includes complimentary access to a companion website, which will update the book's content on a quarterly basis, to keep oncologists, haematologists and other medical practitioners informed of the very latest practice-changing advances. This online resource includes additional images, videos and a comprehensive list of references.

Search for more Oncology related medical journals

To access our daily STM news feed through your iPhone, iPad, or other smartphones, please visit www.myscoope.com for a mobile friendly reading experience.


Click here

Two oncology books by University of Louisville School of Medicine professors released
- 10 Feb 2011

Two University of Louisville School of Medicine professors recently authored reference works in the field of oncology. While one focuses on the use of radiation treatment for childhood cancers, the other is on hepatocellular carcinoma, or liver cancer.

Dr. Edward C. Halperin, dean of the school, is co-author of the fifth edition of Pediatric Radiation Oncology and Dr. Kelly M. McMasters, chair of the Department of Surgery, is co-editor of a new work, Hepatocellular Carcinoma: Targeted Therapy and Multidisciplinary Care.

It is claimed that since 1986, Pediatric Radiation Oncology has been the definitive text and reference on use of radiation therapy for childhood cancer. It reportedly reviews all significant recent clinical trials - including, for the first time, significant European clinical trials - and provides increased coverage of international and Third World issues. The latest cancer staging guidelines are included.

New chapters in the 512-page reference cover psychosocial aspects of radiotherapy for the child and family and medical management of pain, nausea, nutritional problems and blood count depression in the child with cancer. A companion website includes the full text and an image bank.

Dr. Halperin's co-authors are Dr. Louis S. Constine of the University of Rochester Medical Center, Dr. Nancy J. Tarbell of Massachusetts General Hospital and Harvard Medical School and Dr. Larry E. Kun of the University of Tennessee Health Science Center. Pediatric Radiation Oncology is published by Lippincott, Williams and Wilkins.

Hepatocellular Carcinoma seeks to provide a detailed repository of the latest information regarding cancer of the liver, including its epidemiology, diagnosis, imaging, pathology, staging and treatments. Forty-seven chapter authors, including Dr. McMasters, have contributed to the volume. The result is seen to provide an up-to-date guide that explores not only traditional treatments, but newer investigational options. These include surgical resection, liver transplantation, ablation or removal of tissue by radiofrequency or microwaves, and injection of ethanol or acetic acid.

The 430-page work is projected as a comprehensive reference for all healthcare professionals and trainees worldwide who have an interest in the diagnosis and treatment of liver cancer, including surgeons, medical oncologists, radiologists, radiation oncologists and pathologists.

Co-edited by Dr. Jean-Nicholas Vauthey of the University of Texas M.D. Anderson Cancer Center, Hepatocellular Carcinoma is published by Springer Science and Business Media.

Search for more Oncology related Medical books and journals

To access our daily STM news feed through your iPhone, iPad, or other smartphones, please visit www.myscoope.com for a mobile friendly reading experience.


Click here

Elsevier acquires oncology journal portfolio from CIG Media Group
- 03 Feb 2011

STM publisher Elsevier, Netherlands, has announced that it acquired the oncology portfolio of journals previously published by CIG Media Group LP. The journals publish peer-reviewed, disease specific original research and review articles that disseminate cutting-edge data to physicians, medical researchers and healthcare professionals.

These journals will join Elsevier's oncology portfolio and are expected to further enhance the depth and quality of oncology content published by Elsevier. The specific journal titles are: Clinical Breast Cancer, Clinical Lung Cancer, Clinical Lymphoma Myeloma & Leukemia, Clinical Colorectal Cancer, Clinical Ovarian Cancer and Clinical Genitourinary Cancer.

Medical publisher CIG Media Group publishes peer-reviewed, tumor-specific oncology/hematology journals and proceedings for clinical/medical oncologists and hematologists. CIG journals provide the up-to-date, clinically relevant information available and include original study content, comprehensive reviews from research experts, meeting highlights from prominent conferences, expert panels, and current trials.

Search for more Oncology related STM Journals

To access our daily STM news feed through your iPhone, iPad, or other smartphones, please visit www.myscoope.com for a mobile friendly reading experience.


Click here

Springer to publish Cellular Oncology, expands cancer research portfolio
- 01 Feb 2011

STM publisher Springer and the International Society of Cellular Oncology (ISCO) have announced a partnership to publish the journal, Cellular Oncology, starting this year. Cellular Oncology is the official journal of ISCO and publishes original papers and reviews on the latest advances in cancer research. It was previously published by IOS Press.

Cellular Oncology publishes scientific contributions from biomedical and clinical disciplines involved in basic and translational cancer research on the cell and tissue level, technical and bioinformatics developments in this area and clinical applications. The journal seeks to provide a platform of scientific exchange between molecular biologists and geneticists, technical developers, pathologists, oncologists and other clinicians involved in the management of cancer patients.

Cellular Oncology will be available electronically, and in print, on SpringerLink, and six issues per year will be published. Features include Online First, Cross Reference Linking, Electronic Supplementary Material and Alert services.

Search for more Oncology related STM Journals

To access our daily STM news feed through your iPhone, iPad, or other smartphones, please visit www.myscoope.com for a mobile friendly reading experience.


Click here

Springer in deal with Japan Human Cell Society to publish ‘Human Cell’
- 26 Jan 2011

STM publisher Springer has announced that it has been chosen by the Japan Human Cell Society to publish the latter’s official English-language journal, Human Cell, in electronic format. The first online issue will be published at Springer in early 2011. The journal was previously published by Wiley-Blackwell. Dr. Isamu Ishiwata, Director of Ishiwata Obstetric & Gynecologic Hospital in Japan, is the editor-in-chief of the journal.

A quarterly publication, Human Cell serves as a forum for international research on all aspects of human cell biology and related disciplines, publishing original research articles of studies using ES/iPS cells or tissue stem cells derived from human or other species. In addition to showcasing the research activities of the Society, Human Cell also publishes papers in the categories: Cell Line, Rapid Communications, Reviews and Letters to the Editor. The expanded Cell Line section deals with research on the establishment of cell lines, which will serve as a foundation for clinical hot topics such as regenerative medicine and oncologic research.

Springer will publish the e-journal Human Cell starting with Volume 24, Issue 1. The journal will make use of a manuscript tracking system that speeds publication of important articles in the field. The journal will be available via SpringerLink, Springer’s online information platform. Cross Reference Linking and Table of Contents Alert services will be fully implemented for the journal. Springer will digitise the back volumes of Human Cell to 2002, making them available to readers through the Springer Online Archives Collection.

Click here

Elsevier announces inaugural issue of Practical Radiation Oncology journal
- 26 Jan 2011

STM publisher Elsevier, Netherlands, has announced the publication of the first issue of the journal Practical Radiation Oncology (PRO) on behalf of the American Society for Radiation Oncology (ASTRO).

Under the guidance of Editor-in-Chief Dr. W. Robert Lee, PRO aims to improve the quality of radiation oncology practice. The journal will provide background for those in training and continuing education for practitioners, through discussion and illustration of new techniques and evaluation of current practices.

PRO will complement ASTRO’s other official journal, the International Journal of Radiation Oncology∙Biology∙Physics (the Red Journal). While the Red Journal will continue to describe new discoveries in the field, PRO will provide a context on such discoveries for its readers, and immediately usable information. The journal will be distributed to ASTRO members as a benefit of membership, along with the Red Journal.

Click here

Elsevier announces title change for Cancer Genetics and Cytogenetics journal, names new Editor-in-chief
- 07 Dec 2010

STM publisher Elsevier, Netherlands, has announced that the Cancer Genetics and Cytogenetics journal is changing its title to Cancer Genetics. The journal has also named Dr. Jaclyn A. Biegel as editor-in-chief.

The changes reflect broader aims and scope for the journal with a new focus on diagnostic applications as well as the genetic predisposition of cancer. The initiative marks an important move by Elsevier to provide the STM community with a wider variety of original, clinically relevant information for the diagnosis, prognosis and risk evaluation of cancer patients and a greater understanding of how altered gene regulation will ultimately lead to new, targeted therapies for treatment. The first issue of Cancer Genetics will be published in January 2011, with a new cover and interior design.

Editor-in-Chief Dr. Jaclyn A. Biegel is the Director of the Cancer Cytogenetics Laboratory at the Children's Hospital of Philadelphia and a Professor of Pediatrics at the University of Pennsylvania School of Medicine. Her clinical expertise is in the diagnosis of pediatric leukemia and solid tumors. Her research expertise is in the genetics of pediatric brain tumors and rhabdoid tumors.

To access our daily STM news feed through your iPhone, iPad, or other smartphones, please visit www.myscoope.com for a mobile friendly reading experience.


Click here

AACR announces new journal - Cancer Discovery
- 01 Nov 2010

The American Association for Cancer Research has announced the launch of a new journal, Cancer Discovery. The journal combines the expertise and experience of founding Editors-in-Chief Dr. Lewis C. Cantley and Dr. José Baselga along with full-time professional editors. Dr. Mark W. Landis has been appointed executive editor.

Cancer Discovery will publish high-impact, peer-reviewed articles describing major advances in basic and clinical research. Its unique format will feature game-changing research, review articles, perspectives and commentaries, news, and 'Research Watch' summaries of important journal articles. The journal is a new addition to the AACR's robust publication programme.

The journal is currently receiving manuscripts for consideration for publication, and will publish electronically in April 2011 and in print in July 2011.

Search for more Oncology related Scientific Journals


To access our daily STM news feed through your iPhone, iPad, or other smartphones, please visit www.myscoope.com for a mobile friendly reading experience.


Click here

BCF publishes new patient publications
- 09 Aug 2010

The Bone and Cancer Foundation (BCF) has announced the publishing of two new patient publications on Pain Management and Physical Therapy and other Rehabilitation Therapies.

BCF, founded in 2007, seeks to provide information for cancer patients, healthcare professionals and the public on the causes and treatment of cancer involving bone. It offers new resources for patients including a Glossary of words and terms related to cancer and a Frequently Asked Questions section. Other publication topics include breast cancer, prostate cancer, lung cancer, osteonecrosis of the jaw, Vitamin D, surgery, myeloma and osteosarcoma. All publications are available free of charge, both in print and online.

The Foundation is organising a conference for Physicians and other Health Professionals on October 9, 2010, at the University of Pittsburgh. Clinical Perspectives on the Treatment of Bone Metastasis is designed for oncologists, urologists, or other medical professionals who treat cancer patients with bone related complications. Leading medical experts will discuss topics on pathophysiology of bone metastasis, breast cancer and bone metastasis, emerging therapies to prevent skeletal complications in men with prostate cancer, myeloma bone disease and management of cancer therapy induced bone loss. CME credit will be available.

Search for more oncology related medical book/journals

Get customisable STM news alerts in your Mobile. Visit http://www.scopeknowledge.com/scoope.jar via your mobile browser to download the SCOOPE application


Elsevier and International Society of Geriatric Oncology launch Journal of Geriatric Oncology
- 07 Jul 2010

STM publisher Elsevier, Netherlands, and the International Society of Geriatric Oncology (SIOG) have announced the launch of an international, multidisciplinary journal - Journal of Geriatric Oncology.

The Journal of Geriatric Oncology is focused on advancing research in the pathogenesis, biology, treatment and survivorship issues of older adults with cancer. It covers all aspects of geriatric oncology, from basic scientific research through to clinical research, as well as research that is relevant to education and policy development.

The Editorial Board is led by Editor-in-Chief, Dr. Arti Hurria, and Founding Editor, Matti Aapro. Dr Hurria is a geriatrician and oncologist, focusing on care of the older patient with cancer. Dr Aapro is Dean of the Multidisciplinary Oncology Institute at the Clinique de Genolier in Genolier, Switzerland. In addition to his role as Executive Director of SIOG, Dr. Aapro is also an active member of several professional organisations.

Search for more oncology related books/journals

Get customisable STM news alerts in your Mobile. Visit http://www.scopeknowledge.com/scoope.jar via your mobile browser to download the SCOOPE application


Click here

CIG Media Group offers free access to Clinical Breast Cancer
- 25 May 2010

Oncology journals publisher CIG Media Group, US, has announced that it is offering free access to Clinical Breast Cancer at cigjournals.com, in celebration of a decade of publishing Clinical Breast Cancer.

Over the years, Clinical Breast Cancer has developed a strong name as a platform for top-quality clinical content. The journal claims to be the premier source for clinically relevant information, to promote excellence in clinical research, and to facilitate the timely translation of that science to healthcare and clinical practice.

Clinical Breast Cancer has proven to be an excellent communicator of scholarly information, as evidenced by an initial ISI Impact Factor of 2.427. The tenth anniversary issue includes a special review section that discusses the changes in breast cancer research and treatment during the past decade, with an eye toward the future of the field in the coming decade. Featured are review articles by Drs. Lisa Carey, Larry Solin and Doug Reintgen, and Edith Perez.

Search for more oncology related information


Click here

CIG Media Group offers financial aid for cancer support groups
- 03 May 2010

Oncology journals publisher CIG Media Group, US, has announced that it has made a financial endowment to aid local clinical cancer research, and foundations such as the ThriveWell Cancer Foundation that support them. The endowment is aimed to help groups such as Jake Remembered and START, which seek to provide hope and improve options for those with cancer.

CIG Media Group seeks to disseminate clinically relevant information to practicing clinicians through its portfolio of tumour-specific journals. These include Clinical Lung Cancer; Clinical Colorec¬tal Cancer; Clinical Breast Cancer; Clinical Lymphoma, Myeloma & Leukemia; and Clinical Ovarian Cancer.

All of the company's established journals are indexed in PubMed. Each year, CIG Media Group also publishes multiple tumour-specific journal supplements that provide oncology professionals with opportunities to earn Accreditation Council for Continuing Medical Education (ACCME).

Search for more Oncology related medical journals


Universities and research institutions in Germany gain access to Journal of Clinical Oncology Legacy Archive
- 08 Apr 2010

The American Society of Clinical Oncology (ASCO) and the Bavarian State Library (Munich), on behalf of the German Research Foundation, Deutsche Forschungsgemeinschaft (DFG), have completed a nationwide licensing agreement for legacy content from the Society's peer-reviewed Journal of Clinical Oncology (JCO).

Under the agreement, JCO's Legacy Archive content will be available to universities and other publicly-financed research institutions in Germany. The institutions will gain access to over 5,000 articles published in 192 issues of JCO between 1983 and 1998.

The deal is part of a German initiative to improve access to specialised electronic resources for over 170 universities, research institutes and academic libraries, financially supported by DFG and coordinated by major research libraries like the Bavarian State Library.

Search for more Oncology related books/journals


Springer strengthens oncology journals program with Journal of Cancer Education
- 01 Feb 2010

STM publisher Springer, Germany, has announced the addition of the Journal of Cancer Education (JCE) to its journals publishing programme. Published on behalf of the American Association for Cancer Education and the European Association for Cancer Education, the journal features a varied editorial board made up of MDs and PhDs who support the dissemination of information on improving cancer education worldwide. Dr. Joseph F. O'Donnell of the Dartmouth Medical School in Hanover, New Hampshire, USA, will serve as editor-in-chief.

A quarterly publication, the Journal of Cancer Education presents research that aims to improve current cancer education techniques, to solve problems that exist in educating patients and to strengthen existing education programmes. International in scope, it serves as the ideal source to inform physicians, dentists, nurses, students, social workers as well as patients and the general public about various aspects of cancer education.

Articles include original research papers; commentary; book and media reviews; and announcements of educational programs, fellowships and grants. A special column called ‘Reflections’ relates to the human aspects of dealing with cancer and cancer patients and their families.

Search for more Oncology related books/journals

Discuss this NEWS


Click here

The Endocrine Society launches new journal - Hormones & Cancer
- 29 Jan 2010

The Endocrine Society has launched a new journal - Hormones & Cancer. In collaboration with STM publisher Springer Science + Business Media, the Society has created an international editorial board that includes many of the leading experts in this interdisciplinary field of study. Jonathan J. Li of the department of pharmacology, toxicology and therapeutics at Kansas University School of Medicine will serve as the Editor-in chief of the journal.

A bi-monthly publication, Hormones & Cancer will include research articles covering all aspects of hormone action on cancer causation, progression, dependence, prevention, resistance and treatment. Hormonal cancers include two of the most deadly cancer subtypes - cancers of the breast and prostate. In addition to these cancers, journal will include research articles covering other less-commonly occurring cancer subtypes, such as thyroid, gynecologic and pituitary cancer. Bringing together endocrinology and oncology researchers, this new journal will span the multidisciplinary nature of this field of research by including basic scientific, epidemiological and translational research papers.

Hormones & Cancer will be published both electronically and in print. The first issue will be available online February 1, 2010, at http://www.springer.com/medicine/oncology/journal/12672.

Search for more Oncology related books/journals

Discuss this NEWS


Click here

Springer and ISOBM sign co-publishing agreement
- 08 Jan 2010

STM publisher Springer, Germany, has signed an agreement with the International Society of Oncology and BioMarkers (ISOBM) to co-publish the journal Tumor Biology. Starting in January 2010, the global publisher will publish the journal six times a year electronically and in print. Professor Torgny Stigbrand from Umeå University, Umeå, Sweden, will serve as editor-in-chief.

Tumor Biology publishes original research, mini-reviews and commentaries on translational cancer research. The journal places special emphasis on articles covering all aspects of tumor markers and tumor targeting, but studies in other areas of clinical and translational cancer research are also included. Following a multidisciplinary approach, Tumor Biology seeks to provide an important platform for cell and molecular biologists, developmental biologists, pathologists, clinical oncologists and any researcher involved in the study of tumors.

The ISOBM is an international society that seeks to bridge the gap between basic science and clinical application. It provides a forum for discussion and development of novel approaches to clinical problems in cancer. Through annual meetings and antibody workshops, the society aims to support communication among scientists, clinicians and commercial groups.

Search for more oncology related STM books/journals

Disucss this NEWS


Click here

Wiley-Blackwell announces 7th edition of TNM Classification of Malignant Tumours
- 07 Dec 2009

Wiley-Blackwell, the STM and scholarly publishing business of John Wiley & Sons, Inc, US, has announced the release of the latest edition of TNM Classification of Malignant Tumours.

TNM Classification of Malignant Tumours, 7th Edition, offers an international approach to cancer classification and staging, with the latest information and best evidence carefully vetted and included by a multidisciplinary panel of experts from around the world. The material is therefore immediately applicable to patients worldwide, and not influenced by any particular healthcare system. The publication's greatest virtue continues to be its simplicity, distilling and arranging complex data in a way that is immediately applicable wherever cancer patients are seen.

The 7th edition provides the latest, internationally agreed-upon standards to describe and categorise cancer stages and progression. Published in affiliation with the International Union Against Cancer (UICC), this authoritative guide contains important updated organ-specific classifications that oncologists and other professionals who manage patients with cancer need to accurately classify tumours for staging, prognosis and treatment.

The major alterations addressed in this edition concern carcinomas of the oesophagus and the gastroesophageal junction, stomach, lung, appendix, biliary tract, skin, and prostate. In addition, there are several entirely new classifications. These include gastrointestinal carcinoids (neuroendocrine tumours); gastrointestinal stromal tumour; upper aerodigestive mucosal melanoma; Merkel cell carcinoma; uterine sarcomas; intrahepatic cholangiocarcinoma; and adrenal cortical carcinoma.

A new approach has also been adopted to separate anatomical stage groupings from prognostic groupings in which other prognostic factors are added to T, N, and M categories. These new prognostic groupings, as well as the traditional anatomical groupings, are presented for oesophageal and prostate carcinomas.

Search for more Oncology related book/journals in K-Store

Discuss this NEWS


Click here

CIG Media expands ‘Clinical Lymphoma & Myeloma’ to include leukemia content
- 04 Dec 2009

Medical publisher CIG Media Group, US, has announced that its peer-reviewed journal Clinical Lymphoma & Myeloma will now include leukemia content and be officially re-titled Clinical Lymphoma, Myeloma & Leukemia, beginning with the 10th volume. Dr. Jorge E. Cortés has been appointed Editor-in-Chief for leukemia content.

The journal had debuted as Clinical Lymphoma, providing physicians and healthcare professionals with information on combating hematologic malignancies. It later expanded its scope to include myeloma. Leukemia represents the latest content addition.

Clinical Lymphoma, Myeloma & Leukemia includes original articles describing various aspects of clinical and translational research of hematologic malignancies. The journal is devoted to articles on the detection, diagnosis and treatment of lymphoma, myeloma, leukemia and related disorders, including macroglobulinemia, amyloidosis and plasma cell dyscrasias. It welcomes original studies, reviews, perspectives and current trials on these topics.

Search for more such Oncology related books/journals in K-Store

Discuss this NEWS


Dr. Betty Ferrell named new editor of the Journal of Hospice & Palliative Nursing
- 17 Nov 2009

Healthcare publisher Lippincott Williams & Wilkins, part of Wolters Kluwer Health, US, has announced that the Hospice and Palliative Nurses Association (HPNA) has appointed Dr. Betty Ferrell as the new editor of The Journal of Hospice & Palliative Nursing.

With more than 32 years of oncology nursing experience, Dr. Ferrell has focused her clinical expertise and research in pain management, quality of life, and palliative care. She is a Professor and Research Scientist at the City of Hope National Medical Center, Duarte, CA, a fellow of the American Academy of Nursing, a member of the National Cancer Policy Forum and chairperson of the National Consensus Project for Quality Palliative Care. Dr. Ferrell has over 300 publications in peer-reviewed journals and texts, and has authored five books on pain management and palliative care.

Published by Lippincott Williams & Wilkins, The Journal of Hospice & Palliative Nursing is the official journal of the HPNA. Focusing on the clinical, educational and research aspects of care, the journal offers current and reliable information on end-of-life nursing.

Search for more such Oncology related books/journals in K-Store

Discuss this NEWS

Click here

Seventh edition of ‘AJCC Cancer Staging Manual’ launched
- 05 Nov 2009

STM publisher Springer, Germany, has announced the launch of the seventh edition of AJCC Cancer Staging Manual. The manual has been prepared by the American Joint Committee on Cancer (AJCC) in collaboration with its member organisations, including the American Cancer Society, the National Cancer Institute and the American College of Physicians. These organisations work with the AJCC in the promotion of staging at the time of diagnosis in order to achieve better patient outcomes.

It has been observed that physicians and healthcare professionals need a tool to facilitate the uniform description and reporting of cancer. Proper staging is essential to determine appropriate treatment, evaluate results of management and clinical trials and to serve as the standard for local, regional and international reporting on cancer incidence and outcomes. The latest edition of the AJCC Cancer Staging Manual seeks to bring together the relevant, evidence-based criteria for staging of cancer for 52 anatomic primary sites.

The AJCC Cancer Staging Manual is projected as the ‘home base’ product, which includes the rationale and rules for staging; the background explanation of the changes between the sixth and seventh editions; the definitions of tumour, lymph node involvement and metastasis; and stage groupings and histologic grade for 52 primary cancer sites. The manual’s spin-off products are the AJCC Cancer Staging Handbook, which features all the staging information offered in the Manual in a pocket-size book; and the AJCC Cancer Staging Atlas, offering a highly visual representation with hundreds of additional illustrations. The AJCC e-Staging Tool, a web-based staging application designed to help clinicians stage patients in the clinical setting from desktop, laptop or handheld device, will be launched next month.

Search for more such oncology related books/journals K-Store

Discuss this NEWS

Click here

Cold Spring Publishing set to launch new Oncology journal
- 12 Oct 2009

Medical publishing company Cold Spring Publishing, LLC, US, has announced the launch of a clinical journal - The Journal of the Advanced Practitioner in Oncology. The journal is targeted at nurse practitioners, clinical nurse specialists, advanced practice nurses, and physician's assistants who practice in the field of oncology. With a target circulation of over 7,000, the journal will be distributed at no charge to qualifying recipients in the US. The inaugural issue of the journal is scheduled for May 2010. The journal will then publish 6 times a year.

Pamela Hallquist Viale, an oncology nurse consultant and Assistant Clinical Professor at the University of California, San Francisco, School of Nursing, will serve as the Editor-in-Chief of the journal. Viale has over 25 years of experience as an oncology nurse, clinical nurse specialist and oncology nurse practitioner. She has published and lectured widely on a number of topics, with a focus on symptom management and colorectal cancer.

The journal content will include clinical reviews, original research, translational research summaries, pharmacologic reviews, case studies, national practice profiles, news updates, professional development articles, patient information, and more. The journal will also have an on-line platform at www.AdvancedPractitioner.com.

Search for more such Oncology related products in K-Store

Discuss this NEWS


SAGE launches new journal on cancer biology and genetics
- 05 Oct 2009

Academic publisher SAGE has announced the launch of a new journal - Genes & Cancer. The journal will be published monthly beginning in January 2010. Dr. Prem Reddy, founder and previous Editor-in-Chief of the highly-ranked journal Oncogene, will serve as the editor.

The field of cancer research is entering a new and exciting phase where the convergence of information from genomics, bioinformatics, and modern genetics is beginning to provide new clues into how cancer cells overcome growth regulatory pathways. Genes & Cancer will cover all aspects of the structure and function of oncogenes, growth suppressor and apoptotic genes, their role in signal transduction process and the mechanisms by which their expression and function are altered during tumor development.

The journal will publish original studies and reviews that are relevant to all aspects of cancer research, signal transduction, and developmental biology. Topics covered by the journal are divided into four broad categories - the structure and function of cancer-associated genes as well as genes encoded by the DNA and RNA tumor viruses; the role played by these genes in normal development; genomics and epigenomics of cancer; and the discovery and mechanism of action of cancer therapeutics.

Search for more such Oncology related Books/journals in K-Store

Discuss this NEWS


SAGE launches new journal - Therapeutic Advances in Medical Oncology
- 21 Sep 2009

Academic publisher SAGE has launched a new journal - Therapeutic Advances in Medical Oncology. The journal publishes latest research and reviews on systemic cancer treatments including chemotherapy, endocrine therapy, biological therapy and immunotherapy. Charles Coombes will serve as the Editor-in-Chief of the new journal.

Publishing bi-monthly, Therapeutic Advances in Medical Oncology (http://tam.sagepub.com) is the sixth title in SAGE’s Therapeutic Advances (TA) series, following successful launches in cardiology, respiratory disease, neurology, gastroenterology and urology. All the titles, including this one, will be freely available on the SAGE Journals Online platform for the first three years of publication.

The journal is currently seeking submissions for reviews, perspectives and original research articles.

Search for more such Oncology related books/journals in K-Store

Discuss this NEWS


Springer and The Endocrine Society sign publishing agreement
- 31 Aug 2009

STM publisher Springer, Germany, has signed an agreement with The Endocrine Society to co-publish a new journal, Hormones & Cancer, starting in January 2010. Jonathan Li of the Department of Pharmacology, Toxicology, and Therapeutics at Kansas University School of Medicine will serve as the Editor-in chief of the journal.

Hormonal cancers include two of the most deadly cancer subtypes - cancers of the breast and prostate. In addition to these cancers, Hormones & Cancer will include research articles covering other less-commonly occurring cancer subtypes, such as thyroid, gynecologic and pituitary cancer. The journal will help bridge the gap between those working in the two often disconnected fields of endocrinology and cancer research.

Hormones & Cancer is projected to be a translational journal, including basic scientific, epidemiological and clinical research papers. Because of the inherent multidisciplinary nature of the field, it is anticipated that the journal's focus will be on all aspects of hormone action on cancer causation, progression, dependence, prevention, resistance and treatment. Translational studies, especially those utilising novel cancer agents selectively designed to exert their action at hormone target tissues, will also be welcomed.

The journal will be published bimonthly both electronically and in print. The journal will include Cross Reference Linking, alert services, and online first, a feature by which articles are published online before they appear in print. The journal will be available on SpringerLink.com, a comprehensive collection of scientific, technological, and medical journals, books and reference works.

Search for more oncology products in K-Store

Discuss this NEWS


Click here

Springer announces publishing partnership with the Indian Association of Surgical Oncology
- 20 Jul 2009

STM publisher Springer, Germany, has signed a co-publishing agreement with the Indian Association of Surgical Oncology (IASO) to launch the society's official publication, the Indian Journal of Surgical Oncology (IJSO). Dr. Vijay Kumar, Secretary of the Indian Association of Surgical Oncology; Dr. K.S. Gopinath, editor of the IJSO; Dr. William F. Curtis, President of Springer Science+Business Media, LLC; and Sanjiv Goswami, Managing Director of Springer India, signed the agreement at Bangalore.

The Indian Journal of Surgical Oncology, a new quarterly, peer-reviewed, multidisciplinary journal, will accept articles on all the specialised areas of oncology that engage surgeons in the treatment and management of cancer. The journal aims to serve as a medium of publication for original scientific work from India, as well as from around the world. Original articles, review articles and other special articles of importance and interest dealing with basic and clinical research will be considered for publication.

The Indian Journal of Surgical Oncology will be published both electronically and in print. The journal will include Cross Reference Linking, alert services, and Online First, a feature by which articles are published online before they appear in print. Springer will also implement the online author submission system, Editorial Manager. This system allows the peer-review process to be handled faster, resulting in the speedy publication of the articles.

Search for more such STM products in K-Store

Discuss this NEWS


Click here

For banner ads click here